secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0001770787-25-000035
Event type: litigation
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

10x Genomics settles patent litigation with Bruker; to receive $68M upfront plus royalties
--------------------------------------------------------------------------------

- Settled all patent litigation with Bruker (formerly NanoString) regarding spatial biology platforms; all claims dismissed with prejudice.
- 10x expects $68M in upfront nonrefundable payments, paid in equal quarterly installments with interest from Q3 2025 to Q2 2026.
- Ongoing royalty payments on licensed products and services for the life of the licensed patents.
- Litigation began in 2021–2022 targeting NanoString's GeoMx and CosMx spatial platforms; Bruker assumed liabilities in May 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000177078725000035/0001770787-25-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000177078725000035/txg-20250512.htm
  HTML page:      https://secwatch.observer/filing/0001770787-25-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer